Primary-care prescribing of anti-osteoporotic-type medications following hospitalisation for fractures.
AffiliationDepartment of Pharmacology & Therapeutics, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland. firstname.lastname@example.org
Aged, 80 and over
Bone Density Conservation Agents
Medical Record Linkage
Physician's Practice Patterns
Primary Health Care
MetadataShow full item record
CitationPrimary-care prescribing of anti-osteoporotic-type medications following hospitalisation for fractures. 2011, 67 (3):301-8 Eur. J. Clin. Pharmacol.
JournalEuropean journal of clinical pharmacology
AbstractWe examined the prescribing of antiosteoporotic medications pre- and post hospital admission in patients with fragility fractures as well as factors associated with prescribing of these treatments following admission.
We identified all patients aged ≥ 55 years at a large teaching hospital between 2005 and 2008 with a fracture using the Hospital In-Patient Enquiry (HIPE) system. These data were linked to prescribing data from the Health Service Executive Primary Care Reimbursement Services (HSE-PCRS) scheme before and after discharge (821 patients). Logistic regression analysis was used to examine the likelihood of prescription of antiosteoporotic medication pre- and post discharge in relation to year of discharge, age, gender, and type of fracture.
Prescribing of antiosteoporotic treatment before fracture increased from 2.6% [95% confidence interval (CI) 2.23-2.93%] in 2005 to 10.6% (95% CI 9.32-11.86) by 2008, whereas post fracture prescribing increased from 11% (95% CI 9.64-12.36) to 47% (95% CI 43.6-50.3). In patients discharged from hospital in 2007, postfracture prescribing was 31.8% (95% CI 28.66-35.02) at 12 months, increasing to 50.3% (95% CI 46.6-53.9) at 24 months. The highest rate of prescribing was in the 65- to 69-year age group [odds ratio (OR) 8.51, 95% CI 1.75-41.35]. Patients discharged in 2008 were eight times more likely to be treated than patients discharged in 2005 (OR 8.01, 95% CI 4.55-14.09).
The percentage of patients on antiosteoporotic treatment post fracture increased significantly from 2005 to 2008. This may be largely due to the introduction of the Osteoporosis Clinic to the hospital in 2005.
- Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008.
- Authors: McGowan B, Bennett K, Casey MC, Doherty J, Silke C, Whelan B
- Issue date: 2013 Dec
- Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.
- Authors: Gonnelli S, Caffarelli C, Iolascon G, Bertoldo F, Letizia Mauro G, Patti A, Nuti R
- Issue date: 2017 Oct
- Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
- Authors: Shah A, Prieto-Alhambra D, Hawley S, Delmestri A, Lippett J, Cooper C, Judge A, Javaid MK, REFReSH study team.
- Issue date: 2017 Jan
- Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice.
- Authors: McGowan B, Bennett K, Barry M
- Issue date: 2010 Jul
- Undertreatment with anti-osteoporotic drugs after hospitalization for fracture.
- Authors: Panneman MJ, Lips P, Sen SS, Herings RM
- Issue date: 2004 Feb